Sutureless amniotic membrane transplantation

Expert Review of Ophthalmology

Volumn 1, Issue 1, 2006, Pages 49-62

  Kheirkhah, Ahmad ^a   li, Wei ^a   Casas, Victoria ^a   Tseng, Scheffer cg ^b  

^a Ocular Surface Research Education Foundation   (United States)

^b TISSUETECH INC   (United States)

Author keywords

amniotic membrane; band keratopathy; bullous keratopathy; chemical burn; cicatricial ocular disease; conjunctivochalasis; corneal ulcer; limbal stem cell deficiency; pterygium

Indexed keywords

EID: 84899777294     PISSN: 17469899     EISSN: 17469902     Source Type: Journal    
DOI: 10.1586/17469899.1.1.49     Document Type: Article

References (117)

1. Kruse FE, Voelcker HE, Rohrschneider K. Transplantation of amniotic membrane for reconstruction of the eye surface. Ophthalmologe 95, 114–119 (1998).
2. Dua HS, Azuara-Blanco A. Amniotic membrane transplantation. Br. J. Ophthalmol. 83, 748–752 (1999).
3. Sippel KC, Ma JJK, Foster CS. Amniotic membrane surgery. Curr. Opin. Ophthalmol. 12, 269–281 (2001).
4. Tseng SCG. Amniotic membrane transplantation for ocular surface recon-struction. Bioscience Rep. 21, 481–489 (2002).
5. Dua HS, Gomes JA, King AJ, Maharajan VS. The amniotic membrane in ophthalmology. Surv. Ophthalmol. 49, 51–77 (2004).
6. Bouchard CS, John T. Amniotic membrane transplantation in the management of severe ocular surface disease: indications and outcomes. Ocular Surface 2, 201–211 (2004).
7. Kenyon KR. Amniotic membrane: mother’s own remedy for ocular surface disease. Cornea 24, 639–642 (2005).
8. Kim JC, Tseng SCG. Transplantation of preserved human amniotic membrane for surface reconstruction in severely damaged rabbit corneas. Cornea 14, 473–484 (1995).
9. Tseng SCG, Espana EM, Kawakita T et al. How does amniotic membrane work? Ocular Surface 2, 177–187 (2004).
10. Nakamura T, Yoshitani M, Rigby H et al. Sterilized, freeze-dried amniotic membrane: a useful substrate for ocular surface reconstruction. Invest. Ophthalmol. Vis. Sci. 45, 93–99 (2004).
11. Nakamura T, Inatomi T, Sekiyama E et al. Novel clinical application of sterilized, freeze-dried amniotic membrane to treat patients with pterygium. Acta Ophthalmol. Scand. 84, 401–405 (2006).
12. Tsai RJF, Li L-M, Chen J-K. Reconstruction of damaged corneas by transplantation of autologous limbal epithelial cells. N. Engl. J. Med. 343, 86–93 (2000).
13. Schwab IR, Reyes M, Isseroff RR. Successful transplantation of bioengineered tissue replacements in patients with ocular surface disease. Cornea 19, 421–426 (2000).
14. Koizumi N, Inatomi T, Suzuki T, Sotozono C, Kinoshita S. Cultivated corneal epithelial stem cell transplantation in ocular surface disorders. Ophthalmology 108, 1569–1574 (2001).
15. Solomon A, Touhami A, Sandoval H, Tseng SCG. Neurotrophic keratopathy: basic concepts and therapeutic strategies. Comp. Ophthalmol. Update 3, 165–174 (2000).
16. Lee S-H, Tseng SCG. Amniotic membrane transplantation for persistent epithelial defects with ulceration. Am. J. Ophthalmol. 123, 303–312 (1997).
17. Kruse FE, Rohrschneider K, Völcker HE. Multilayer amniotic membrane transplantation for reconstruction of deep corneal ulcers. Ophthalmology 106, 1504–1511 (1999).
18. Azuara-Blanco A, Pillai CT, Dua HS. Amniotic membrane transplantation for ocular surface reconstruction. Br. J. Ophthalmol. 8339, 399–402 (1999).
19. Gabric N, Mravicic I, Dekaris I, Karaman Z, Mitrovic S. Human amniotic membrane in the reconstruction of the ocular surface. Doc. Ophthalmol. 98, 273–283 (1999).
20. Chen H-J, Pires RTF, Tseng SCG. Amniotic membrane transplantation for severe neurotrophic corneal ulcers. Br. J. Ophthalmol. 84, 826–833 (2000).
21. Hanada K, Shimazaki J, Shimmura S, Tsubota K. Multilayered amniotic membrane transplantation for severe ulceration of the cornea and sclera. Am. J. Ophthalmol. 131, 324–331 (2001).
22. Solomon A, Meller D, Prabhasawat P et al. Amniotic membrane grafts for nontraumatic corneal perforations, descemetoceles, and deep ulcers. Ophthalmology 109, 694–703 (2002).
23. Letko E, Stechschulte SU, Kenyon KR et al. Amniotic membrane inlay and overlay grafting for corneal epithelial defects and stromal ulcers. Arch. Ophthalmol. 119, 659–663 (2001).
24. Rodriguez-Ares MT, Tourino R, Lopez-Valladares MJ, Gude F. Multilayer amniotic membrane transplantation in the treatment of corneal perforations. Cornea 23, 577–583 (2004).
25. Hick S, Demers PE, Brunette I, La C, Mabon M, Duchesne B. Amniotic membrane transplantation and fibrin glue in the management of corneal ulcers and perforations: a review of 33 cases. Cornea 24, 369–377 (2005).
26. Prabhasawat P, Tesavibul N, Komolsuradej W. Single and multilayer amniotic membrane transplantation for persistent corneal epithelial defect with and without stromal thinning and perforation. Br. J. Ophthalmol. 85, 1455–1463 (2001).
27. Duchesne B, Tahi H, Galand A. Use of human fibrin glue and amniotic membrane transplant in corneal perforation. Cornea 20, 230–232 (2001).
28. Kim JS, Kim JC, Hahn TW, Park WC. Amniotic membrane transplantation in infectious corneal ulcer. Cornea 20, 720–726 (2001).
29. Chen JH, Ma DH, Tsai RJ. Amniotic membrane transplantation for pseudomonal keratitis with impending perforation. Chang Gung Med. J. 25, 144–152 (2002).
30. Ma DH-K, Wang SF, Su WY, Tsai RJF. Amniotic membrane graft for the management of scleral melting and corneal perforation in recalcitrant infectious scleral and corneoscleral ulcers. Cornea 21, 275–283 (2002).
31. Pires RTF, Tseng SCG, Prabhasawat P et al. Amniotic membrane transplantation for symptomatic bullous keratopathy. Arch. Ophthalmol. 117, 1291–1297 (1999).
32. Mrukwa-Kominek E, Gierek-Ciaciura S, Rokita-Wala I, Szymkowiak M. Use of amniotic membrane transplantation for treating bullous keratopathy. Klin. Oczna 104, 41–46 (2002).
33. Mejia LF, Santamaria JP, Acosta C. Symptomatic management of postoperative bullous keratopathy with nonpreserved human amniotic membrane. Cornea 21, 342–345 (2002).
34. Espana EM, Grueterich M, Sandoval H et al. Amniotic membrane transplantation for bullous keratopathy in eyes with poor visual potential. J. Cat. Refract. Surg. 29, 279–284 (2003).
35. Anderson DF, Prabhasawat P, Alfonso E, Tseng SCG. Amniotic membrane transplantation after the primary surgical management of band keratopathy. Cornea 20, 354–361 (2001).
36. Prabhasawat P, Kosrirukvongs P, Booranapong W, Vajaradul Y. Amniotic membrane transplantation for ocular surface reconstruction. J. Med. Assoc. Thai 84, 705–718 (2001).
37. Tosi GM, Traversi C, Schuerfeld K et al. Amniotic membrane graft: histopathological findings in five cases. J. Cell Physiol. 202, 852–857 (2005).
38. Lavker RM, Tseng SC, Sun T-T. Corneal epithelial stem cells at the limbus: looking at some old problems from a new angle. Exp. Eye Res. 78, 433–446 (2004).
39. Puangsricharern V, Tseng SCG. Cytologic evidence of corneal diseases with limbal stem cell deficiency. Ophthalmology 102, 1476–1485 (1995).
40. Tseng SCG. Regulation and clinical implications of corneal epithelial stem cells. Mol. Biol. Rep. 23, 47–58 (1996).
41. Holland EJ, Schwartz GS. Changing concepts in the management of severe ocular surface disease over twenty-five years. Cornea 19, 688–698 (2000).
42. Kim JC, Tseng SCG. The effects on inhibition of corneal neovascularization after human amniotic membrane transplantation in severely damaged rabbit corneas. Korean J. Ophthalmol. 9, 32–46 (1995).
43. Tseng SCG, Prabhasawat P, Barton K, Gray T, Meller D. Amniotic membrane transplantation with or without limbal allografts for corneal surface reconstruction in patients with limbal stem cell deficiency. Arch. Ophthalmol. 116, 431–441 (1998).
44. Anderson DF, Ellies P, Pires RT, Tseng SC. Amniotic membrane transplantation for partial limbal stem cell deficiency. Br. J. Ophthalmol. 85, 567–575 (2001).
45. Gomes JA, dos Santos MS, Cunha MC, Mascaro VL, Barros JN, de Sousa LB. Amniotic membrane transplantation for partial and total limbal stem cell deficiency secondary to chemical burn. Ophthalmology 110, 466–473 (2003).
46. Sangwan VS, Matalia HP, Vemuganti GK, Rao GN. Amniotic membrane transplantation for reconstruction of corneal epithelial surface in cases of partial limbal stem cell deficiency. Indian J. Ophthalmol. 52, 281–285 (2004).
47. Meallet MA, Espana EM, Grueterich M, Ti SE, Goto E, Tseng SC. Amniotic membrane transplantation with conjunctival limbal autograft for total limbal stem cell deficiency. Ophthalmology 110, 1585–1592 (2003).
48. Tseng SCG, Prabhasawat P, Lee S-H. Amniotic membrane transplantation for conjunctival surface reconstruction. Am. J. Ophthalmol. 124, 765–774 (1997).
49. Shields CL, Shields JA, Armstrong T. Management of conjunctival and corneal melanoma with surgical excision, amniotic membrane allograft, and topical chemotherapy. Am. J. Ophthalmol. 132, 576–578 (2001).
50. Paridaens D, Beekhuis H, van Den Bosch W, Remeyer L, Melles G. Amniotic membrane transplantation in the management of conjunctival malignant melanoma and primary acquired melanosis with atypia. Br. J. Ophthalmol. 85, 658–661 (2001).
51. Chen Z, Yan J, Yang H et al. Amniotic membrane transplantation for conjunctival tumor. Yan Ke Xue Bao 19, 165–7, 145 (2003).
52. Dalla PG, Ghirlando A, Busato F, Midena E. Reconstruction of conjunctiva with amniotic membrane after excision of large conjunctival melanoma: a long-term study. Eur. J. Ophthalmol. 15, 446–450 (2005).
53. Prabhasawat P, Tseng SCG. Impression cytology study of epithelial phenotype of ocular surface reconstructed by preserved human amniotic membrane. Arch. Ophthalmol. 115, 1360–1367 (1997).
54. Meller D, Tseng SCG. Conjunctivochalasis: literature review and possible pathophysiology. Surv. Ophthalmol. 43, 225–232 (1998).
55. Di Pascuale MA, Espana EM, Kawakita T, Tseng SC. Clinical characteristics of dry eye caused by conjunctivochalasis with or without aqueous tear deficiency. Br. J. Ophthalmol. 88, 388–392 (2004).
56. Meller D, Maskin SL, Pires RTF, Tseng SCG. Amniotic membrane transplantation for symptomatic conjunctivochalasis refractory to medical treatments. Cornea 19, 796–803 (2000).
57. Georgiadis NS, Terzidou CD. Epiphora caused by conjunctivochalasis: treatment with transplantation of preserved amniotic membrane. Cornea 20, 619–621 (2001).
58. Barton K, Budenz D, Khaw PT, Tseng SCG. Glaucoma filtration surgery using amniotic membrane transplantation. Invest. Ophthalmol. Vis. Sci. 42, 1762–1768 (2001).
59. Demir T, Turgut B, Akyol N, Ozercan I, Ulas F, Celiker U. Effects of amniotic membrane transplantation and mitomycin C on wound healing in experimental glaucoma surgery. Ophthalmologica 216, 438–442 (2002).
60. Fujishima H, Shimazaki J, Shinozaki N, Tsubota K. Trabeculectomy with the use of amniotic membrane for uncontrolled glaucoma. Ophthalmic Surg. Lasers 29, 428–431 (1998).
61. Inoue T, Hirata A, Kimura A, Sonoda S, Tanihara H. Mitomycin C trabeculectomy in an eye with cicatricial conjunctiva following amniotic membrane transplantation. Acta Ophthalmol. Scand. 81, 673–674 (2003).
62. Budenz DL, Barton K, Tseng SCG. Amniotic membrane transplantation for repair of leaking glaucoma filtering blebs. Am. J. Ophthalmol. 130, 580–588 (2000).
63. Kee C, Hwang JM. Amniotic membrane graft for late-onset glaucoma filtering leaks. Am. J. Ophthalmol. 133, 834–835 (2002).
64. Di Pascuale M, Espana EM, Kawakita T, Tseng SCG. Surgical management of pterygium. Contemporary Ophthalmology 4, 213–222 (2003).
65. Essex RW, Snibson GR, Daniell M, Tole DM. Amniotic membrane grafting in the surgical management of primary pterygium. Clin. Experiment Ophthalmol. 32, 501–504 (2004).
66. Ma DH-K, See L-C, Liau S-B, Tsai RJF. Amniotic memrane graft for primary pterygium: comparison with conjunctival autograft and topical mitomycin C treatment. Br. J. Ophthalmol. 84, 973–978 (2000).
67. Prabhasawat P, Barton K, Burkett G, Tseng SCG. Comparison of conjunctival autografts, amniotic membrane grafts and primary closure for pterygium excision. Ophthalmology 104, 974–985 (1997).
68. Tananuvat N, Martin T. The results of amniotic membrane transplantation for primary pterygium compared with conjunctival autograft. Cornea 23, 458–463 (2004).
69. Solomon A, Pires RTF, Tseng SCG. Amniotic membrane transplantation after extensive removal of primary and recurrent pterygia. Ophthalmology 108, 449–460 (2001).
70. Kawasaki S, Uno T, Shimamura I, Ohashi Y. Outcome of surgery for recurrent pterygium using intraoperative application of mitomycin C and amniotic membrane transplantation. Nippon Ganka Gakkai Zasshi 107, 316–321 (2003).
71. Ma DH, See LC, Hwang YS, Wang SF. Comparison of amniotic membrane graft alone or combined with intraoperative mitomycin C to prevent recurrence after excision of recurrent pterygia. Cornea 24, 141–150 (2005).
72. Sangwan VS, Murthy SI, Bansal AK, Rao GN. Surgical treatment of chronically recurring pterygium. Cornea 22, 63–65 (2003).
73. Yao YF, Qiu WY, Zhang YM, Tseng SC. Mitomycin C, amniotic membrane transplantation and limbal conjunctival autograft for treating multirecurrent pterygia with symblepharon and motility restriction. Graefes Arch. Clin. Exp. Ophthalmol. 244, 232–236 (2006).
74. Honavar SG, Bansal AK, Sangwan VS, Rao GN. Amniotic membrane transplantation for ocular surface reconstruction in Stevens-Johnson syndrome. Ophthalmology 107, 975–979 (2000).
75. Tseng SCG, Di Pascuale MA, Liu D-Z, Gao Y-Y, Baradaran-Rafii A. Intraoperative mitomycin C and amniotic membrane transplantation for fornix reconstruction in severe cicatricial ocular surface diseases. Ophthalmology 112, 896–903 (2005).
76. Nava-Castaneda A, Tovila-Canales JL, Monroy-Serrano MH et al. Comparative study of amniotic membrane transplantation, with and without simultaneous application of mitomycin C in conjunctival fornix reconstruction. Arch. Soc. Esp. Oftalmol. 80, 345–352 (2005).
77. Rodriguez-Ares MT, Tourino R, Capeans C, Sanchez-Salorio M. Repair of scleral perforation with preserved scleral amniotic membrane in Marfan’s syndrome. Ophthalmic Surg. Lasers 30, 485–487 (1999).
78. Reim M, Teping C. Surgical procedures in the treatment of severe eye burns. Acta Ophthalmol. (Copenh.) 67 (Suppl.), 47–54 (1989).
79. Kenyon KR, Tseng SC. Limbal autograft transplantation for ocular surface disorders. Ophthalmology 96, 709–722 (1989).
80. Pires RTF, Chokshi A, Tseng SCG. Amniotic membrane transplantation or limbal conjunctival autograft for limbal stem cell deficiency induced by 5-fluorouracil in glaucoma surgeries. Cornea 19, 284–287 (1999).
81. Shimazaki J, Kosaka K, Shimmura S, Tsubota K. Amniotic membrane transplantation with conjunctival autograft for recurrent pterygium 1. Ophthalmology 110, 119–124 (2003).
82. Santos MS, Gomes JA, Hofling-Lima AL, Rizzo LV, Romano AC, Belfort R Jr. Survival analysis of conjunctival limbal grafts and amniotic membrane transplantation in eyes with total limbal stem cell deficiency. Am. J. Ophthalmol. 140, 223–230 (2005).
83. Tsubota K, Satake Y, Ohyama M et al. Surgical reconstruction of the ocular surface in advanced ocular cicatricial pemphigoid and Stevens-Johnson syndrome. Am. J. Ophthalmol. 122, 38–52 (1996).
84. Tsubota K, Satake Y, Kaido M et al. Treatment of severe ocular surface disorders with corneal epithelial stem-cell transplantation. N. Engl. J. Med. 340, 1697–1703 (1999).
85. Solomon A, Ellies P, Anderson DF et al. Long-term outcome of keratolimbal allograft with or without penetrating keratoplasty for total limbal stem cell deficiency. Ophthalmology 109, 1159–1166 (2002).
86. Ikari L, Daya SM. Long-term outcomes of keratolimbal allograft for the treatment of severe ocular surface disorders. Ophthalmology 109, 1278–1284 (2002).
87. Espana EM, Grueterich M, Ti SE, Tseng SC. Phenotypic study of a case receiving a keratolimbal allograft and amniotic membrane for total limbal stem cell deficiency. Ophthalmology 110, 481–486 (2003).
88. Jurowski P, Gos I. Kerato limbal allografts and multilaye ramniotic membrane transplantation in the treatment of ocular surface disease due to chemical burns. Klin. Oczna 106, 648–652 (2004).
89. Kim JS, Kim JC, Na BK, Jeong JM, Song CY. Amniotic membrane patching promotes healing and inhibits protease activity on wound healing following acute corneal alkali burns. Exp. Eye Res. 70, 329–337 (1998).
90. Meller D, Pires RTF, Mack RJS et al. Amniotic membrane transplantation for acute chemical or thermal burns. Ophthalmology 107, 980–990 (2000).
91. Sridhar MS, Bansal AK, Sangwan VS, Rao GN. Amniotic membrane transplantation in acute chemical and thermal injury. Am. J. Ophthalmol. 130, 134–137 (2000).
92. Kobayashi A, Shirao Y, Yoshita T et al. Temporary amniotic membrane patching for acute chemical burns. Eye 17, 149–158 (2003).
93. Pan DP, Li XX, Xu JF. Therapeutic effect of amniotic membrane transplantation for ocular burn. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi 17, 318–320 (2003).
94. John T, Foulks GN, John ME, Cheng K, Hu D. Amniotic membrane in the surgical management of acute toxic epidermal necrolysis. Ophthalmology 109, 351–360 (2002).
95. Di Pascuale MA, Espana EM, Liu DT et al. Correlation of corneal complications with eyelid cicatricial pathologies in patients with Stevens-Johnson syndrome and toxic epidermal necrolysis syndrome. Ophthalmology 112, 904–912 (2005).
96. Heiligenhaus A, Meller D, Meller D, Steuhl K-P, Tseng SCG. Improvement of HSV-1 necrotizing keratitis with amniotic membrane transplantation. Invest. Ophthalmol. Vis. Sci. 42, 1969–1974 (2001).
97. Sridhar MS, Sangwan VS, Bansal AK, Rao GN. Amniotic membrane transplantation in the management of shield ulcers of vernal keratoconjunctivitis. Ophthalmology 108, 1218–1222 (2001).
98. Heinz C, Eckstein A, Steuhl KP, Meller D. Amniotic membrane transplantation for reconstruction of corneal ulcer in graves ophthalmopathy. Cornea 23, 524–526 (2004).
99. Hong JW, Kang SM, Kim HJ, Kim HM. The effect of phototherapeutic keratectomy (PTK)-photorefractive keratectomy (PRK)- amniotic membrane transplantation (AMT) on myopic regression with corneal opacity after PRK in high myopia. Invest. Ophthalmol. Vis. Sci. 39, S354 (1998).
100. Kim JY, Wee WR, Choi YS, Lee JH. Clinical outcome of photorefractive keratectomy (PRK) retreatment using amniotic membrane. Ophthalmology 162 (1998).
101. Choi YS, Kim JY, Wee WR, Lee JH. Effect of the application of human amniotic membrane on rabbit corneal wound healing after excimer laser photorefractive keratectomy. Cornea 17, 389–395 (1998).
102. Park WC, Tseng SCG. Modulation of acute inflammation and keratocyte death by suturing, blood and amniotic membrane in PRK. Invest. Ophthalmol. Vis. Sci. 41, 2906–2914 (2000).
103. Wang MX, Gray TB, Parks WC et al. Corneal haze and apoptosis is reduced by amniotic membrane matrix in excimer laser photoablation in rabbits. J. Cat. Refract. Surg. 27, 310–319 (2001).
104. Kaminski SL, Lacombe E, Duchesne B et al. Supradescemetic keratoprosthesis (SD-Kpro): a novel design. Invest. Ophthalmol. Vis. Sci. 43, 2993 (2002).
105. Kruse FE, Joussen AM, Rohrschneider K et al. Cryopreserved human amniotic membrane for ocular surface reconstruction. Graefes Arch. Clin. Exp. Ophthalmol. 238, 68–75 (2000).
106. Koranyi G, Seregard S, Kopp ED. The cut-and-paste method for primary pterygium surgery: long-term follow-up. Acta Ophthalmol. Scand. 83, 298–301 (2005).
107. Uy HS, Reyes JM, Flores JD, Lim-Bon-Siong R. Comparison of fibrin glue and sutures for attaching conjunctival autografts after pterygium excision. Ophthalmology 112, 667–671 (2005).
108. Kobayashi A, Ijiri S, Sugiyama K, Di Pascuale MA, Tseng SC. Detection of corneal epithelial defect through amniotic membrane patch by fluorescein. Cornea 24, 359–360 (2005).
109. Yoshita T, Kobayashi A, Takahashi M, Sugiyama K. Reliability of intraocular pressure by Tono-Pen XL over amniotic membrane patch in human. J. Glaucoma 13, 413–416 (2004).
110. Espana EM, Di Pascuale M, Grueterich M, Solomon A, Tseng SC. Keratolimbal allograft in corneal reconstruction. Eye 18, 406–417 (2004).
111. Shimazaki J, Shimmura S, Fujishima H, Tsubota K. Association of preoperative tear function with surgical outcome in severe Stevens-Johnson syndrome. Ophthalmology 107, 1518–1523 (2000).
112. Gris O, Campo Z, Wolley-Dod C et al. Amniotic membrane implantation as a therapeutic contact lens for the treatment of epithelial disorders. Cornea 21, 22–27 (2002).
113. Khokhar S, Sharma N, Kumar H, Soni A. Infection after use of nonpreserved human amniotic membrane for the reconstruction of the ocular surface. Cornea 20, 773–774 (2001).
114. Marangon FB, Alfonso EC, Miller D, Remonda NM, Muallem MS, Tseng SCG. Incidence of microbial infection after amniotic membrane transplantation. Cornea 23, 264–269 (2004).
115. Schechter BA, Rand WJ, Nagler RS et al. Corneal melt after amniotic membrane transplant. Cornea 24, 106–107 (2005).
116. Messmer EM. Hypopyon after amniotic membrane transplantation. Ophthalmology 108, 1714–1715 (2001).
117. Gabler B, Lohmann CP. Hypopyon after repeated transplantation of human amniotic membrane onto the corneal surface. Ophthalmology 107, 1344–1346 (2000).